Reed SG - Search Results

1

In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.

van Haren SD, Ganapathi L, Bergelson I, Dowling DJ, Banks M, Samuels RC, Reed SG, Marshall JD, Levy O. van Haren SD, et al. Among authors: reed sg. Cytokine. 2016 Jul;83:99-109. doi: 10.1016/j.cyto.2016.04.001. Epub 2016 Apr 12. Cytokine. 2016. PMID: 27081760 Free PMC article. Clinical Trial.

2

Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization.

van Haren SD, Dowling DJ, Foppen W, Christensen D, Andersen P, Reed SG, Hershberg RM, Baden LR, Levy O. van Haren SD, et al. Among authors: reed sg. J Immunol. 2016 Dec 1;197(11):4413-4424. doi: 10.4049/jimmunol.1600282. Epub 2016 Oct 28. J Immunol. 2016. PMID: 27793997 Free PMC article.

3

New horizons in adjuvants for vaccine development.

Reed SG, Bertholet S, Coler RN, Friede M. Reed SG, et al. Trends Immunol. 2009 Jan;30(1):23-32. doi: 10.1016/j.it.2008.09.006. Epub 2008 Dec 6. Trends Immunol. 2009. PMID: 19059004 Review.

4

Use of defined TLR ligands as adjuvants within human vaccines.

Duthie MS, Windish HP, Fox CB, Reed SG. Duthie MS, et al. Among authors: reed sg. Immunol Rev. 2011 Jan;239(1):178-96. doi: 10.1111/j.1600-065X.2010.00978.x. Immunol Rev. 2011. PMID: 21198672 Free PMC article. Review.

5

The importance of adjuvant formulation in the development of a tuberculosis vaccine.

Baldwin SL, Bertholet S, Reese VA, Ching LK, Reed SG, Coler RN. Baldwin SL, et al. Among authors: reed sg. J Immunol. 2012 Mar 1;188(5):2189-97. doi: 10.4049/jimmunol.1102696. Epub 2012 Jan 30. J Immunol. 2012. PMID: 22291184 Free PMC article.

6

The science of vaccine adjuvants: advances in TLR4 ligand adjuvants.

Reed SG, Hsu FC, Carter D, Orr MT. Reed SG, et al. Curr Opin Immunol. 2016 Aug;41:85-90. doi: 10.1016/j.coi.2016.06.007. Epub 2016 Jul 5. Curr Opin Immunol. 2016. PMID: 27392183 Review.

7

Synthetic and natural TLR4 agonists as safe and effective vaccine adjuvants.

Fox CB, Friede M, Reed SG, Ireton GC. Fox CB, et al. Among authors: reed sg. Subcell Biochem. 2010;53:303-21. doi: 10.1007/978-90-481-9078-2_14. Subcell Biochem. 2010. PMID: 20593273

8

Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis.

Raman VS, Bhatia A, Picone A, Whittle J, Bailor HR, O'Donnell J, Pattabhi S, Guderian JA, Mohamath R, Duthie MS, Reed SG. Raman VS, et al. Among authors: reed sg. J Immunol. 2010 Aug 1;185(3):1701-10. doi: 10.4049/jimmunol.1000238. Epub 2010 Jul 2. J Immunol. 2010. PMID: 20601594 Free PMC article.

9

A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93.

Orr MT, Beebe EA, Hudson TE, Moon JJ, Fox CB, Reed SG, Coler RN. Orr MT, et al. Among authors: reed sg. PLoS One. 2014 Jan 3;9(1):e83884. doi: 10.1371/journal.pone.0083884. eCollection 2014. PLoS One. 2014. PMID: 24404140 Free PMC article.

10

The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction.

Dubois Cauwelaert N, Desbien AL, Hudson TE, Pine SO, Reed SG, Coler RN, Orr MT. Dubois Cauwelaert N, et al. Among authors: reed sg. PLoS One. 2016 Jan 5;11(1):e0146372. doi: 10.1371/journal.pone.0146372. eCollection 2016. PLoS One. 2016. PMID: 26731269 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

454 results

Search Page